Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
2.010
+0.190 (10.44%)
At close: May 12, 2025, 4:00 PM
2.020
+0.010 (0.49%)
After-hours: May 12, 2025, 6:49 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Antibody-Based Therapeutics
850.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
850.00K